EMGenisys offers an embryo health assessment platform that determines embryo viability and sex in a single assessment in the lab.
EMGenisys has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
EMGenisys's investors include Tall Grass Ventures, Luminate, Ag Ventures Alliance, Texas A&M Innovation, Grit Road Partners.
EMGenisys is headquartered in Houston, United States.
EMGenisys offers an embryo health assessment platform that determines embryo viability and sex in a single assessment in the lab.
EMGenisys is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EMGenisys — Funding & Investors." VCBacked, July 23, 2025, https://www.vcbacked.co/company/emgenisys. Accessed August 1, 2026.
VCBacked. (2025). EMGenisys — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/emgenisys
{{cite web |title=EMGenisys — Funding & Investors |url=https://www.vcbacked.co/company/emgenisys |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated